Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-07-04
2006-07-04
McKane, Joseph K. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S217090, C514S234500, C514S254060, C514S322000, C514S338000, C514S403000, C540S603000, C544S119000, C544S357000, C544S371000, C546S199000, C546S275700, C548S360100
Reexamination Certificate
active
07071182
ABSTRACT:
The present invention relates to the antagonism of the effects of melanin-concentrating hormone (MCH) through the melanin concentrating hormone receptor which is useful for the prevention or treatment of eating disorders, weight gain, obesity, abnormalities in reproduction and sexual behavior, thyroid hormone secretion, diuresis and water/electrolyte homeostasis, sensory processing, memory, sleeping, arousal, anxiety, depression, seizures, neurodegeneration and psychiatric disorders.
REFERENCES:
patent: 2003015769 (2003-02-01), None
patent: WO 2004078748 (2004-09-01), None
CAS Abstract attached.
Collins Christine A.
Gao Ju
Judd Andrew S.
Kym Philip R.
Mulhern Mathew M.
Abbott Laboratories
Corbin Johanna M.
McKane Joseph K.
Nolan Jason M.
LandOfFree
Antagonists of melanin concentrating hormone effects on the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antagonists of melanin concentrating hormone effects on the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antagonists of melanin concentrating hormone effects on the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3562053